Private equity firm KKR & Co. Inc. has invested $250 million in Henry Schein Inc., Long Island’s largest publicly traded ...

NEW YORK, Jan 22 (Reuters) - Activist investor Ananym Capital Management plans to nominate as many as half a dozen directors to the board at Henry Schein (HSIC.O), opens new tab, arguing the ...

Henry Schein announced today that private equity firm KKR is investing $250 million in the medical products manufacturer and ...

Private equity firm KKR has taken a large stake in Henry Schein and reached a deal to add members to the company's board, the ...

Ananym Capital Management, an activist investor, has plans to nominate up to six directors to the board of Henry Schein (NASDAQ:HSIC), a dental and medical distributor. According to a Reuters report, ...

Providing a diverse range of perspectives from bullish to bearish, 5 analysts have published ratings on Henry Schein HSIC in the last three months. The table below offers a condensed view of their ...

Henry Schein HSIC is well positioned to gain from its extensive global foothold and diverse channel mix. Yet, global economic uncertainties are concerns for Henry Schein. The stock carries a Zacks ...

The stock's fall snapped a two-day winning streak.

This belief drove our collaboration with Henry Schein One, a division of Henry Schein, a leader in dental software solutions, to launch a dynamic new website designed to set the standard for ...

Henry Schein said it expects to report earnings and revenue growth in the fourth quarter and forecast further gains in 2025 adjusted earnings, even as it confirmed an activist-investment deal with ...

NEW YORK (Reuters) - Activist investor Ananym Capital Management plans to nominate as many as half a dozen directors to the board at Henry Schein, arguing the dental and medical distributor needs ...